Performance Measure Portfolio

The HIV/AIDS Bureau performance measure portfolio focuses on critical areas of HIV care and treatment, and aligns with milestones along the HIV care continuum. The performance measure portfolio focuses on:

Identifying core performance measures that are most critical to the care and treatment of people with HIV
Combining performance measures to address people of all ages with HIV
Promoting relevant performance measures used in other federal programs
Archiving performance measures that are no longer consistent with U.S. Department of Health and Human Services guidelines or applicable to the general population

The HIV/AIDS Bureau encourages Ryan White HIV/AIDS Program recipients to use the revised performance measures, including the core performance measures. The core performance measures completed the rigorous National Quality Forum infectious disease endorsement process.

Given the emphasis on using performance measures to improve health of people with HIV, recipients may trend performance measure data over time and analyze the data for disparities in care. Disparity analyses may include review data for difference in performance in gender, race/ethnicity, age, insurance status, HIV risk, and others.

Use of Technology to Provide Services

HRSA's HIV/AIDS Bureau performance measures often include a medical visit in numerator or denominator. A medical visit is an encounter between a patient and a provider with prescribing privileges (such as a physician, nurse practitioner, or physician assistant). A medical visit can occur face-to-face, via telehealth, and in other settings. HIV/AIDS Bureau Policy Clarification Notice #16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals & Allowable Uses of Funds (PDF - 172 KB) states HRSA's Ryan White HIV/AIDS Program recipients are encouraged to consider all methods or means by which they can provide services, including use of technology (e.g., telehealth); and Outpatient/Ambulatory Health Services settings may include: clinics, medical offices, mobile vans, using telehealth technology, and urgent care facilities for HIV-related visits.

The revised performance measure portfolio is outlined below.

Performance Measures and Frequently Asked Questions

Category	Documentation
Frequently Asked Questions: General Information Children Oral Health System Adolescent/Adult	General FAQ (PDF - 44 KB) Children FAQ (PDF - 65 KB) Oral Health FAQ (PDF - 37 KB) System FAQ (PDF - 51 KB) Adolescent/Adult FAQ (PDF - 174 KB)
Core: HIV Viral Suppression Prescription of HIV Antiretroviral Therapy HIV Medical Visit Frequency Gap in HIV Medical Visits PCP Prophylaxis Annual Retention in Care	Core Measures
All Ages: HIV Drug Resistance Testing Before Initiation of Therapy Influenza Immunization Lipid Screening Tuberculosis Screening	All Ages Measures
Adolescent/Adult: Cervical Cancer Screening Chlamydia Screening Gonorrhea Screening Hepatitis B Screening Hepatitis B Vaccination Hepatitis C Screening HIV Risk Counseling Oral Exam Pneumococcal Vaccination Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Substance Abuse Screening Syphilis Screening	Adolescent and Adult Measures
Children: MMR Vaccination	Children Measures
HIV-Exposed Children: Diagnostic Testing to Exclude HIV Infection in Exposed Infants Neonatal Zidovudine Prophylaxis PCP Prophylaxis for HIV-Exposed Infants	HIV Exposed Children Measures
Medical Case Management (MCM): Care Plan Gap in HIV Medical Visits HIV Medical Visit Frequency	MCM Measures
Oral Health: Dental and Medical History Dental Treatment Plan Oral Health Education Periodontal Screening or Examination Phase I Treatment Plan Completion	Oral Health Measures
Systems-Level: Waiting Time for Initial Access to Outpatient/Ambulatory Medical Care HIV Test Results for People Living with HIV HIV Positivity Late HIV Diagnosis Linkage to HIV Medical Care Housing Status	System Measures
AIDS Drug Assistance Program (ADAP): ADAP Application Determination (REVISED) ADAP Inappropriate Anti-Retroviral Regimen (REVISED) Viral Suppression for ADAP Clients Loss of ADAP Services Due to Failure to Confirm Eligibility Timely Payment of Health Insurance Premiums Enrollment in Health Care Coverage (including Medicaid, Medicare Part D and private health insurance)	ADAP Measures

Category	Downloads
Archived:	All Archived Measures (PDF - 682 KB)
ADAP: *Application Determination Eligibility Recertification Formulary Inappropriate Anti-Retroviral Regimen	Archived ADAP Measures (PDF - 280 KB)
Adolescent/Adult: ARV Therapy for Pregnant Women CD4 T-Cell Count HAART Medical Visits PCP Prophylaxis Adherence Assessment and Counseling Tuberculosis Screening Hepatitis/HIV Alcohol Counseling Influenza Vaccination MAC Prophylaxis Mental Health Screening Tobacco Screening Toxoplasma Screening	Archived Adolescent Adult Measures (PDF - 180 KB)
Pediatrics: Adherence Assessment and Counseling ARV Therapy CD4 Value Developmental Surveillance Health Care Transition Planning for HIV-infected Youth HIV Drug Resistance Testing Before Initiation of Therapy Lipid Screening Medical Visit PCP Prophylaxis for HIV-Infected Children Planning for Disclosure of HIV Status to Child Tuberculosis Screening	Archived Pediatric Measures (PDF - 65 KB)
All Ages: CD4 Count Viral Load Suppression on ART Viral Load Monitoring	Archived All Ages Measures (PDF - 120 KB)
Medical Case Management (MCM): Medical Visits	Archived MCM Measures (PDF - 19 KB)
System: Disease Status at Time of Entry Into Care Quality Management Program	Archived System Measures (PDF - 34 KB)

Fecha de la última revisión:

March 2024

Performance Measures and Frequently Asked Questions

Archived Performance Measure Downloads